KDOQI (Kidney Disease Outcomes Quality Initiative)


KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease


1°Pr Primary prevention
2°Ir Secondary intervention
4D Deutsche Diabetes Dialyse Studie
ABCD Appropriate Blood Pressure Control in Diabetes
ACC American College of Cardiology
ACCORD Action to Control Cardiovascular Risk in Diabetes
ACE Angiotensin-converting enzyme
ACE-I Angiotensin-converting enzyme inhibitor
ACR Albumin-creatinine ratio
ADA American Diabetes Association
AER Albumin excretion rate
AG Atubular glomeruli
AHA American Heart Association
Alb Albuminuria
ALLHAT Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
ANP Atrial natriuretic peptide
ARB Angiotensin receptor blocker
ARR Absolute risk reduction
ATP III National Cholesterol Education Program Adult Treatment Panel III
AURORA A study to evaluate the use of Rosuvastatin in subjects on regular hemodialysis: an assessment of survival and cardiovascular events
BENEDICT Bergamo Nephrologic Diabetes Complications Trial
BMI Body mass index
BorderlineAlb Borderline albuminuria
BP Blood pressure
CAD Coronary artery disease
CARDS Collaborative Atorvastatin Diabetes Study
CARE Cholesterol and Recurrent Events
CCB Calcium channel blocker
CCr Creatinine clearance
CI Confidence interval
CIT Conventional insulin injection therapy
CKD Chronic kidney disease
CORAL Cardiovascular Outcomes in Renal Atherosclerotic Lesions
COX-2 Cyclooxygenase-2
CPG Clinical Practice Guideline
CPR Clinical Practice Recommendation
Cr Creatinine
CREATE Clinical Trial of Reviparin and Metabolic Modulation in Acute Myocardial Infarction Treatment Evaluation
CR-LIPE Carbohydrate-restricted, low iron-available, polyphenol-enriched diet
CSG Collaborative Study Group
CT Computed tomography
CV Coefficient of variation
CVD Cardiovascular disease
CYP Cytochrome P-450
DALY Disability-adjusted life-year
DASH Dietary Approaches to Stop Hypertension
DBP Diastolic blood pressure
DCCT The Diabetes Control and Complications Trial
DCCT/EDIC Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications
ddAVP 1-Deamino-8-D-arginine
DETES Diabetics Exposed to Telmisartan and Enalapril Study Group
DGS Diabetic glomerulosclerosis
DHA Docosahexaenoic acid
DHP-CCB Dihydropyridine calcium channel blocker
DIABHYCAR Noninsulin-dependent diabetes, hypertension, microalbuminuria or proteinuria, cardiovascular events, and ramipril
DIAD Detection of Ischemia in Asymptomatic Diabetics
DIGAMI Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction
DKD Diabetic kidney disease
DM Diabetes mellitus
DPP-4 Dipeptidyl peptidase-4
ECG Electrocardiogram
ECLA Estudios Cardiologicas Latin America Study Group
EDIC Epidemiology of Diabetes Interventions and Complications
eGFR Estimated glomerular filtration rate
EPA Eicosapentaenoic acid
ESRD End-stage renal disease
FBS Fasting blood sugar
FDA Food and Drug Administration
FPW Foot process width on the mesangial surface
GBM Glomerular basement membrane
GEMINI Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives
GFR Glomerular filtration rate
GIK Glucose-insulin-potassium infusion
glom Glomerulus
GLP-1 Glucagon-like-peptide-1
GlycoHb Glycohemoglobin
GS Glomerular sclerosis
HbA1c Hemoglobin A1c
HD Hemodialysis
HDL-C High-density lipoprotein cholesterol
HIV/AIDS Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome
HOPE Heart Outcomes Prevention Evaluation
HPS Heart Protection Study
HR Hazard ratio
HTN Hypertension
ICU Intensive care unit
IDL Intermediate-density lipoprotein
IDNT Irbesartan Diabetic Nephropathy Trial
IJA Index of junctional atrophy
IRMA-2 Irbesartan in Patients With Type 2 Diabetes and Microalbuminuria
IU International units
IUGR Intrauterine growth retardation
IV Intravenous
JNC 7 Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
KDOQI™ Kidney Disease Outcomes Quality Initiative™
Kf Ultrafiltration coefficient
KRT Kidney replacement therapy
LDL-C Low-density lipoprotein cholesterol
LIPID Long-term Intervention with Pravastatin in Ischemic Disease
LPD Lower-protein diet
LVH Left ventricular hypertrophy
M Macroalbuminuria
m Microalbuminuria
MacroAlb Macroalbuminuria
MAP Mean arterial blood pressure
MDRD Modification of Diet in Renal Disease
MI Myocardial infarction
MicroAlb Microalbuminuria
MIT Multiple insulin injection therapy
N Number of subjects
NCEP National Cholesterol Education Program
nd Not documented
NDHP-CCB Nondihydropyridine calcium channel blocker
NHANES III Third National Health and Nutrition Examination Survey
NHLBI National Heart, Lung, and Blood Institute
NIDDM Non–insulin-dependent diabetes mellitus
NIH National Institutes of Health
NKF National Kidney Foundation
Nl Cr Normal serum creatinine
No Number
NormoAlb Normoalbuminuria
NPH Neutral Protamine Hagedorn
NPV Negative predictive value
NS Not significant
OEI Obesity Education Initiative Expert Panel on Identification, Evaluation, and Treatment of Overweight and Obesity in Adults
OR Odds ratio
P Proteinuria
PCI Percutaneous coronary intervention
PCr Plasma creatinine
PO By mouth, orally
PPP Pravastatin Pooling Project
PPV Positive predictive value
PRESTO Prevention of Restenosis with Tranilast and its Outcomes
PROactive Prospective Pioglitazone Clinical Trial in Macrovascular Events
PROVE IT Pravastatin or Atorvastatin in Evaluation and Infection Therapy
PUFA Polyunsaturated fatty acids
PVD Peripheral vascular disease
qd Daily
QOL Quality of life
RAS Renin-angiotensin system
RCN Radiocontrast-induced nephropathy
RCT Randomized controlled trial
RDA Recommended daily allowance
RDS Respiratory distress syndrome
RENAAL Reduction of Endpoints in Non-insulin-dependent diabetes with the Angiotensin II Antagonist Losartan
ROC Receiver operator characteristic
RR Relative risk
SBP Systolic blood pressure
SCr Serum creatinine (mg/dL)
SFA Saturated fatty acids
SG Globally sclerosed glomeruli
SGA Small for gestational age
SHARP Study of Heart and Renal Protection
SMBG Self-monitoring of blood glucose
Sn Sensitivity
SOLVD Studies Of Left Ventricular Dysfunction
Sp Specificity
Sv(PGBM/glom) Surface density of peripheral GBM per glomerulus
SvME Mesangial to epithelial interface
T Total kidney cortex
TBM Tubular basement membrane
TC Total cholesterol
TNT Treating to New Targets
TZD Thiazolidinedione
UAE Urinary albumin excretion
UKPDS UK Prospective Diabetes Study
UPD Usual/higher protein diet
USRDS United States Renal Data System
VA Veterans Affairs

Very low-density lipoprotein

vs Versus
Vv(AT/cortex) Volume fraction of atrophic tubules per cortex
Vv(Int/cortex) Volume fraction of cortical interstitium
Vv(Interstitium/tubulointerstitium) Volume fraction of interstitium
Vv(MC/glom) Volume fraction of mesangial cells per glomerulus
Vv(Mes/glom) Volume fraction of mesangium per glomerulus
Vv(MM) Volume fraction of mesangial matrix
Vv(MM/glom) Volume fraction of mesangial matrix per glomerulus
Vv(PT/cortex) Volume fraction of proximal tubules
WHO World Health Organization
WOSCOP West of Scotland Coronary Prevention Study

Back to top | Main Page